Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A E Chang

Showing results (31-40 of 169) with videos related to

Pageof 17
Sort By:
Journal of Surgical Oncology|April 28, 1999
Useful techniques for the resection of foot melanomasR A Cowles, T M Johnson, A E Chang
Cancer|October 22, 1998
The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer SocietyA E Chang, L H Karnell, H R Menck
Cellular Immunology|May 1, 1989
Distinct immunologic specificity of tumor regression mediated by effector cells isolated from immunized and tumor-bearing miceA E Chang, D M Perry-Lalley, S Shu
Seminars in Surgical Oncology|September 1, 1994
Diagnostic procedures and pretreatment evaluation of soft tissue sarcomasM J Arca, V K Sondak, A E Chang
Surgery|January 1, 1990
Repeat hepatic resections for colorectal metastasesK D Griffith, P H Sugarbaker, A E Chang
Seminars in Oncology|February 1, 1996
Genetic approaches to adoptive cellular therapy of malignancyM J Arca, J J Mulé, A E Chang
Journal of Biological Response Modifiers|October 1, 1984
Systemic administration of recombinant human interleukin-2 in miceA E Chang, C L Hyatt, S A Rosenberg
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1988
Adoptive immunotherapy of microscopic and advanced visceral metastases with in vitro sensitized lymphoid cells from mice bearing progressive tumorsT Chou, S Bertera, A E Chang, et al.
Cancer Research|September 15, 1993
Cross-reactivity of anti-CD3/IL-2 activated effector cells derived from lymph nodes draining heterologous clones of a murine tumorT Matsumura, R A Krinock, A E Chang, et al.
Cellular Immunology|May 1, 1991
Activation by anti-CD3 of tumor-draining lymph node cells for specific adoptive immunotherapyH Yoshizawa, K Sakai, A E Chang, et al.
Pageof 17

Showing results (31-40 of 169) with videos related to

Sort By:
Pageof 17
Journal of Surgical Oncology|April 28, 1999
Useful techniques for the resection of foot melanomasR A Cowles, T M Johnson, A E Chang
Cancer|October 22, 1998
The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer SocietyA E Chang, L H Karnell, H R Menck
Cellular Immunology|May 1, 1989
Distinct immunologic specificity of tumor regression mediated by effector cells isolated from immunized and tumor-bearing miceA E Chang, D M Perry-Lalley, S Shu
Seminars in Surgical Oncology|September 1, 1994
Diagnostic procedures and pretreatment evaluation of soft tissue sarcomasM J Arca, V K Sondak, A E Chang
Surgery|January 1, 1990
Repeat hepatic resections for colorectal metastasesK D Griffith, P H Sugarbaker, A E Chang
Seminars in Oncology|February 1, 1996
Genetic approaches to adoptive cellular therapy of malignancyM J Arca, J J Mulé, A E Chang
Journal of Biological Response Modifiers|October 1, 1984
Systemic administration of recombinant human interleukin-2 in miceA E Chang, C L Hyatt, S A Rosenberg
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1988
Adoptive immunotherapy of microscopic and advanced visceral metastases with in vitro sensitized lymphoid cells from mice bearing progressive tumorsT Chou, S Bertera, A E Chang, et al.
Cancer Research|September 15, 1993
Cross-reactivity of anti-CD3/IL-2 activated effector cells derived from lymph nodes draining heterologous clones of a murine tumorT Matsumura, R A Krinock, A E Chang, et al.
Cellular Immunology|May 1, 1991
Activation by anti-CD3 of tumor-draining lymph node cells for specific adoptive immunotherapyH Yoshizawa, K Sakai, A E Chang, et al.
Pageof 17